开发用于向蛋白质降解的寡合曼诺-6-酸盐合物
Christopher M Stevens1, Yaxian Zhou1, Peng Teng1
1Lachman Institute for Pharmaceutical Development, School of Pharmacy, University of Wisconsin - Madison Madison, Wisconsin 53705, United States.
ACS medicinal chemistry letters
|June 14, 2023
概括
色素向嵌合体 (LYTACs) 是一种新的蛋白质降解技术. 研究人员为LYTACs开发了曼诺-6-酸盐 (M6Pn) - 联体,通过曼诺-6-酸盐受体 (M6PR) 实现向蛋白质降解.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 色素向嵌合体 (LYTAC) 是一种针对向蛋白质降解的新兴策略.
- LYTACs利用细胞内部化通路向 lysosomes 提供细胞外蛋白质进行降解.
- 曼-6酸盐受体 (M6PR) 是LYTAC技术中使用的关键内化受体.
研究的目的:
- 开发用于LYTAC应用的新型曼诺-6-酸盐 (M6Pn) - 联体.
- 使用M6PR通路实现细胞外蛋白的向降解.
- 促进基于M6Pn的LYTACs的治疗开发.
主要方法:
- 结构定义的M6Pn-联体的合成.
- 将M6Pn-与各种向配体的结合.
- 通过M6PR.评估M6Pn-LYTACs对蛋白质内部化和溶酶体降解的评估.
主要成果:
- 成功开发了一系列明确的M6Pn-联体.
- 证明M6Pn-LYTACs通过M6PR.有能力通过M6PR.内部化和降解目标细胞外蛋白.
- 确定了基于M6Pn的结合物的广泛治疗应用的潜力.
结论:
- M6Pn-联体是开发LYTACs的有效工具.
- 这种方法可以通过M6PR.实现细胞外蛋白的向降解.
- 开发的基于M6Pn的LYTAC对治疗干预具有重大前景.
相关概念视频
Oligosaccharide Assembly
2.9K
Protein glycosylation starts in the ER lumen and continues in the Golgi apparatus. Glycosyltransferases catalyze the addition of sugar molecules or glycosylation of proteins. Usually, these enzymes add sugars to the hydroxyl groups of selected serine or threonine residues to form O-linked glycans or the amino groups of asparagine residues to form N-linked glycans. Different positions on the same polypeptide chain can contain differently linked glycans.
Multiple sugar molecules that may or may...
Multiple sugar molecules that may or may...
2.9K
Regulated Protein Degradation
7.4K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.4K
Export of Misfolded Proteins out of the ER
3.7K
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
3.7K
The Proteasome
913
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
913
Drug Metabolism: Phase II Reactions
3.9K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
3.9K
Proteoglycans
4.0K
Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
4.0K


